Copernicus Group IRB announces the release of CGIRB Connexus® 2.0
Connexus, CGIRB’s award-winning e-document management system, is utilized by sponsors, CROs, and sites to manage every phase of the IRB review process. Connexus 2.0 aims to give a complete upgrade to the system’s look and feel, offering a cleaner, faster and more intuitive experience, while still giving users the ability to track submissions, access an electronic file cabinet of all IRB documents and receive instant notification when a submission is complete.
“When it was originally released, Connexus created a major shift in the IRB industry,” said Jennifer Sodrel, CGIRB’s Director, Information Management. “With Connexus 2.0, we’ve updated the look of the user interface, as well as reworking elements to make it simpler to use and moreintuitive. We took care to make sure users of the original Connexus will beable to transition to the new version very easily.”
New features in Connexus 2.0 include:
- Cleaner inboxes for workspace managers.
- Instant access to live chat with CGIRB support personnel
- Links to CGIRB news on the Connexus login screen, for the latest information
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
